I

InDex Pharmaceuticals Holding AB
STO:FLERIE

Watchlist Manager
InDex Pharmaceuticals Holding AB
STO:FLERIE
Watchlist
Price: 45 SEK 0.78% Market Closed
Market Cap: 3.5B SEK
Have any thoughts about
InDex Pharmaceuticals Holding AB?
Write Note

Net Margin
InDex Pharmaceuticals Holding AB

-190 353%
Current
-248 041.8%
Average
4.5%
Industry

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-190 353%
=
Net Income
-190.4m
/
Revenue
100k

Net Margin Across Competitors

Country SE
Market Cap 3.5B SEK
Net Margin
-190 353%
Country JP
Market Cap 776 550.9T JPY
Net Margin
-79%
Country US
Market Cap 788.1B USD
Net Margin
20%
Country UK
Market Cap 440.4B GBP
Net Margin
-4%
Country DK
Market Cap 3.4T DKK
Net Margin
35%
Country US
Market Cap 384.8B USD
Net Margin
17%
Country US
Market Cap 259.4B USD
Net Margin
22%
Country CH
Market Cap 213.6B CHF
Net Margin
20%
Country UK
Market Cap 171.2B GBP
Net Margin
13%
Country CH
Market Cap 183.5B CHF
Net Margin
33%
Country US
Market Cap 160.4B USD
Net Margin
7%

Profitability Report

View the profitability report to see the full profitability analysis for InDex Pharmaceuticals Holding AB.

See Also

Discover More
What is Net Margin?

Net Margin measures how much net income is generated as a percentage of revenues received. It helps investors assess if a company's management is generating enough profit from its sales and whether operating costs and overhead costs are being contained.

Net Margin
-190 353%
=
Net Income
-190.4m
/
Revenue
100k
What is the Net Margin of InDex Pharmaceuticals Holding AB?

Based on InDex Pharmaceuticals Holding AB's most recent financial statements, the company has Net Margin of -190 353%.